British National Formulary for Children 2021-2022

(9)
British National Formulary for Children 2021-2022 image
ISBN-10:

0857114166

ISBN-13:

9780857114167

Edition: 1
Released: Sep 01, 2021
Format: Paperback, 1264 pages

Description:

Trusted by healthcare professionals across the world to support confident decision-making at the point of care. The new edition provides up-to-date guidance on prescribing, dispensing, and administering medicines to children, plus legal and professional guidelines. Recommendations in the BNF for Children have been constructed on the basis of authoritative sources, emerging evidence, best practice guidelines and advice from a network of paediatric experts. The process is overseen by a paediatric formulary committee.

Best prices to buy, sell, or rent ISBN 9780857114167




Frequently Asked Questions about British National Formulary for Children 2021-2022

You can buy the British National Formulary for Children 2021-2022 book at one of 20+ online bookstores with BookScouter, the website that helps find the best deal across the web. Currently, the best offer comes from and is $ for the .

The price for the book starts from $8.99 on Amazon and is available from 8 sellers at the moment.

At BookScouter, the prices for the book start at $4.32. Feel free to explore the offers for the book in used or new condition from various booksellers, aggregated on our website.

If you’re interested in selling back the British National Formulary for Children 2021-2022 book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.

As for the British National Formulary for Children 2021-2022 book, the best buyback offer comes from and is $ for the book in good condition.

The British National Formulary for Children 2021-2022 book is in very low demand now as the rank for the book is 7,534,434 at the moment. A rank of 1,000,000 means the last copy sold approximately a month ago.

Not enough insights yet.